Study Reveals How Herpes Simplex Virus Manipulates Host Immune Pathway During Infection
Researchers have identified a complex interplay between the herpes simplex virus type 1 (HSV-1) and the host cell's Hippo kinases MST1 and MST2, showing that the virus uses its ICP0 and US3 proteins to counteract antiviral defenses triggered by these kinases. The Hippo pathway, known for regulating cell growth and organ development, has previously been linked to immune function through observations that humans with MST1 loss-of-function mutations suffer recurrent HSV infections. The findings illuminate new mechanisms by which HSV-1 manipulates host cell biology, potentially opening avenues for antiviral therapeutic development.
A preprint study posted to bioRxiv investigated how HSV-1 interacts with the Hippo pathway kinases MST1 and MST2 in human epithelial cells. The researchers found that HSV-1 infection triggers proteolytic cleavage of full-length MST1/2 into smaller N-terminal fragments (MST1/2-NT), which enhance apoptosis and carry antiviral properties. Viral mutants lacking the ICP0 or US3 proteins showed elevated MST1/2-NT production and increased apoptosis, while overexpression of MST1-NT significantly reduced HSV-1 replication, confirming the antiviral role of this cleavage. The study also found that host caspases cleave MST1 and MST2 with differential preferences depending on the infection context, suggesting multiple regulatory layers governing MST1/2-NT production. Interestingly, double-knockout of MST1/2 had minimal effect on wild-type HSV-1 replication but substantially reduced early DNA uptake of ICP0-deficient virus, pointing to a distinct role for full-length MST1/2 in early stages of infection. Together, the results reveal that full-length and cleaved forms of these Hippo kinases play separate and sometimes opposing roles during HSV-1 infection, with the virus deploying ICP0 as a multifaceted countermeasure.
What's missing
As a preprint, this study has not yet undergone peer review, so its findings should be treated as preliminary. The study was conducted in HEp-2 epithelial cells, and it remains unclear whether the same mechanisms operate in other relevant cell types such as neurons, which are critical to HSV-1 latency and pathogenesis. The precise molecular mechanism by which ICP0 suppresses MST1/2 cleavage is not fully resolved, and in vivo validation in animal models is absent.
What different sources said
- bioRxivCenter
Multifaceted regulations of HSV-1 ICP0 on the Anti-Viral Restrictions Imposed by the Host Hippo Kinases Reprogramming
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.